Cargando…

Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis

Low-density lipoprotein receptor-related protein-1 (LRP1) is a multifunctional uptake receptor for chylomicron remnants in the liver. In vascular smooth muscle cells LRP1 controls reverse cholesterol transport through platelet-derived growth factor receptor β (PDGFR-β) trafficking and tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Yinyuan, Xian, Xunde, Holland, William L., Tsai, Shirling, Herz, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913705/ https://www.ncbi.nlm.nih.gov/pubmed/27322467 http://dx.doi.org/10.1016/j.ebiom.2016.04.002

Ejemplares similares

Low-density lipoprotein particle size in hepatic steatosis and metabolic syndrome
por: Kim, Dal-Sik, et al.
Publicado: (2010)

LRP1 integrates murine macrophage cholesterol homeostasis and inflammatory responses in atherosclerosis
por: Xian, Xunde, et al.
Publicado: (2017)

Reducing endogenous insulin is linked with protection against hepatic steatosis in mice
por: Akheruzzaman, Md, et al.
Publicado: (2020)

Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension
por: Calvier, Laurent, et al.
Publicado: (2022)

Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis
por: Radlinger, Bernhard, et al.
Publicado: (2022)

Epicatechin Protects against Corticosteroid Induced Hepatic Steatosis
por: Thomas, Jeffrey, et al.
Publicado: (2014)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Adipose-Specific Deficiency of Fumarate Hydratase in Mice Protects Against Obesity, Hepatic Steatosis, and Insulin Resistance
por: Yang, Hao, et al.
Publicado: (2016)

Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Blocking Nuclear Factor-Kappa B Protects against Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
por: Zeng, Tianshu, et al.
Publicado: (2016)

Peripancreatic adipose tissue protects against high-fat-diet-induced hepatic steatosis and insulin resistance in mice
por: Chanclón, Belén, et al.
Publicado: (2020)

Cordyceps inhibits ceramide biosynthesis and improves insulin resistance and hepatic steatosis
por: Li, Ying, et al.
Publicado: (2022)

Molecular mechanisms involved in hepatic steatosis and insulin resistance
por: Matsuzaka, Takashi, et al.
Publicado: (2011)

Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis
por: Cao, Hui, et al.
Publicado: (2017)

Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice
por: Li, Fengfeng, et al.
Publicado: (2022)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation
por: Eshraghian, Ahad, et al.
Publicado: (2023)

Trypanosoma cruzi Utilizes the Host Low Density Lipoprotein Receptor in Invasion
por: Nagajyothi, Fnu, et al.
Publicado: (2011)

Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion
por: Dannecker, Corinna, et al.
Publicado: (2021)

Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
por: Visser, M. E., et al.
Publicado: (2011)

Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity
por: Kern, Matthias, et al.
Publicado: (2012)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Six-Transmembrane Epithelial Antigen of Prostate 3 Promotes Hepatic Insulin Resistance and Steatosis
por: Ding, Ting, et al.
Publicado: (2022)

Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice
por: Krumm, Christopher S., et al.
Publicado: (2021)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance Through ERα/HGF/Met Pathway
por: Zhang, Yu-Yao, et al.
Publicado: (2017)

ATM protects against oxidative stress induced by oxidized low-density lipoprotein
por: Semlitsch, Michaela, et al.
Publicado: (2011)

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
por: Kiefer, F. W., et al.
Publicado: (2011)

Vanadium(IV)-Chlorodipicolinate Protects against Hepatic Steatosis by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammation
por: Wang, Yuanli, et al.
Publicado: (2022)

Glycerol-3-Phosphate Acyltransferase 1 Deficiency in ob/ob Mice Diminishes Hepatic Steatosis but Does Not Protect Against Insulin Resistance or Obesity
por: Wendel, Angela A., et al.
Publicado: (2010)

Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance
por: Kang, Hong Soon, et al.
Publicado: (2011)

Nuciferine protects against high-fat diet-induced hepatic steatosis and insulin resistance via activating TFEB-mediated autophagy–lysosomal pathway
por: Du, Xiliang, et al.
Publicado: (2022)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1g593qusqojepelamjr9nlc9f2